What Akumin does

Akumin Inc. is a U.S. national provider of outpatient diagnostic imaging and radiation therapy services, headquartered in Tampa, Florida, and operating as a privately held company following its delisting from the TSX. The company runs 124 fixed-site outpatient imaging centers across 14 states, the nation's largest mobile imaging fleet, and the Akumin AXIS line of relocatable imaging suites (including a 1.5T MRI and a patent-pending mobile PET/CT Drop Trailer), partnering with more than 800 hospitals, health systems, and physician groups. Service offerings span MRI (wide-bore, open, upright, and specialty exams), PET/CT (including PSMA PET/CT for prostate cancer), CT, digital X-ray, ultrasound (including echocardiography and TRUS), 3D mammography, nuclear medicine, DEXA bone density, MRA, calcium scoring, and EKG, along with radiation therapy/oncology delivered in outpatient settings.

The business is built on a hybrid B2B/B2C model. Akumin generates revenue from per-exam imaging and radiation therapy services billed primarily through insurance reimbursement at its fixed-site centers, from mobile imaging services deployed to partner facilities, and from enterprise partner solutions structured as joint ventures, managed services, interim/mobile arrangements, oncology services, and urology solutions (mobile PET/CT, MRI, radiopharmaceuticals, and staffing). Customer segments are hospitals and health systems seeking to expand imaging capacity without capital outlay, physician groups requiring diagnostic capability for their patients, and individual patients accessing outpatient imaging directly. Supporting infrastructure includes a physician portal for electronic order and results management, an EMR-agnostic interoperability stack (HL7, Direct Messaging, PowerShare cloud image exchange, Athenahealth integration, and lightweight installer tools), and RadSite standards committee participation for accreditation.

Operationally, Akumin has been in a financial restructuring phase: in late 2025, Stonepeak committed a $154.5 million investment to support an exchange offer for 2027 and 2028 senior secured notes, extend maturities, and provide new growth capital, with over 99% of noteholders tendering by the February 2026 early deadline. The company is pairing this balance sheet repair with the commercial launch of the Akumin AXIS relocatable imaging line, deepened technology partnership with Siemens Healthineers, and continued integration into cloud-based EMR and image exchange ecosystems, positioning it as a turnaround-stage national outpatient imaging platform rather than an early-stage growth company.

Name

Akumin

Legal name

Akumin Inc.

Website

https://akumin.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Akumin Inc. is a U.S. national outpatient diagnostic imaging and radiation therapy provider operating 124 fixed-site centers across 14 states, the nation's largest mobile imaging fleet, and the Akumin AXIS relocatable imaging line, serving 800+ hospitals, health systems, physician groups, and individual patients.

Ownership category

akta.pro rank

Product category

Outpatient Diagnostic Imaging Services

NAICS

Diagnostic Imaging Centers (621512), Ambulatory Health Care Services (621)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

akta.pro secondary industries

Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound) (HLAFAKAA), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI), Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web) (HLACALAI)

Keywords

• Outpatient diagnostic imaging
• Radiation therapy services
• Medical imaging centers
• Mobile imaging fleet
• Oncology treatment services

Headquarters

HQ city

Jenkintown

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Diagnostic Imaging Services: Revenue generated from providing advanced diagnostic imaging services including MRI, PET/CT, CT, X-ray, Nuclear Medicine, DEXA, and 3D Mammography through fixed-site outpatient centers and mobile units
2. Radiation Therapy / Oncology Services: Comprehensive oncology and radiation therapy solutions for cancer treatment delivered in outpatient settings
3. Partner Solutions: Revenue from joint ventures, managed services, interim & mobile solutions, and urology solutions offered to hospitals, health systems, and physician groups
4. Mobile Imaging Services: Revenue from mobile imaging fleet providing flexible diagnostic imaging solutions across multiple locations

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Akumin owns and operates a national network of 124 outpatient diagnostic imaging centers across 14 US states, complemented by the nation's largest mobile imaging fleet and Akumin AXIS relocatable clinics. The company delivers advanced diagnostic imaging (MRI, PET/CT, CT, X-ray, Nuclear Medicine, DEXA, 3D Mammography) and radiation therapy/oncology services, partnering with more than 800 hospitals, health systems, and physician groups through joint ventures, managed services, and interim & mobile solutions.

Product overview

Akumin is a national provider of outpatient diagnostic imaging and radiation therapy/oncology services, operating a unified platform of owned and/or managed outpatient imaging centers, the nation's largest mobile imaging fleet, and Akumin AXIS relocatable clinics — partnering with over 800 hospitals, health systems, and physician groups. The product portfolio is organized around three core service pillars: Radiology Procedures (MRI/PET-CT/CT/X-ray/Nuclear Medicine/DEXA/3D Mammography), Oncology Treatment (radiation therapy), and Partner Solutions (joint ventures, managed services, interim & mobile solutions, oncology services, urology solutions). Akumin AXIS is the company's relocatable imaging suite sub-brand offering fixed relocatable MRI (1.5T Siemens Healthineers) and the patent-pending Drop Trailer mobile PET/CT unit. Supporting infrastructure includes a Physician Portal for order and results management, PowerShare cloud image exchange integration, and interoperability options spanning HL7, Direct Messaging, Athenahealth EMR, and lightweight installer tools. Akumin also participates in RadSite's accreditation programs for advanced diagnostic imaging quality and safety standards.

Differentiator

Problem solved

Functional benefit

Brands

• Akumin AXIS: Relocatable imaging suite line featuring mobile MRI and PET/CT units including the Akumin AXIS 1.5T MRI with Siemens Healthineers Magnetom Viato technology and the patent-pending Akumin AXIS Drop Trailer mobile imaging unit.

Products and services

• Akumin AXIS Relocatable imaging suite line offering mobile and modular imaging solutions, including fixed relocatable 1.5T MRI units and the patent-pending Drop Trailer mobile PET/CT unit with step-free patient access, designed for direct hospital deployment.
• PET/CT Imaging Positron Emission Tomography and Computed Tomography combined in a single exam, providing both metabolic and anatomical information. Includes standard PET/CT and PSMA PET/CT for prostate cancer detection, offered across fixed-site and mobile/network locations.
• MRI (Magnetic Resonance Imaging) Diagnostic imaging using radio waves and a strong magnetic field to visualize internal organs without ionizing radiation. Includes Wide-Bore MRI (1.5T-3T), Open MRI, Upright MRI, prostate MRI, cardiac MRI, and NeuroQuant brain MRI analysis.
• 3D Mammography (Breast Tomosynthesis) FDA-approved breast imaging technology that captures multiple slices of the breast at various angles and reconstructs them into a 3D image, improving cancer detection over standard 2D mammography. Offered as screening and diagnostic mammograms.
• CT Scan (Computed Tomography) Diagnostic imaging combining X-ray technology with computer processing to generate detailed cross-sectional images of the body for head/neck, chest, abdomen/pelvis, musculoskeletal, oncology, cardiac (CCTA), and low-dose lung screening applications.
• Digital X-ray General radiography providing quick imaging for chest, abdominal, KUB, neck, hand, joint, and skull exams.
• Ultrasound Imaging using high-frequency sound waves to create real-time pictures of internal organs and blood vessels, applied in prenatal care, abdominal, pelvic, vascular, cardiac, and procedure guidance contexts.
• Echocardiography Ultrasound scan of the heart and surrounding blood vessels, including transthoracic (TTE), transesophageal (TEE), Doppler, and color Doppler assessments of blood flow.
• Electrocardiography (EKG/ECG) Records the electrical signals of the heart via electrode patches. Three types: Resting EKG, Stress/Exercise EKG, and Ambulatory EKG (1-2 day portable monitoring).
• Magnetic Resonance Angiography (MRA) Uses MRI technology to examine the condition of blood vessels and identify narrow or blocked vessels, performed with or without IV contrast.
• Renal Ultrasound Ultrasound imaging of the kidneys, renal pelvis, and optionally the bladder to assess renal disease, infection, congenital abnormalities, parenchymal disease, and kidney stones.
• Prostate Ultrasound (TRUS) Transrectal ultrasound (TRUS) for prostate and seminal vesicle imaging, used for benign prostate enlargement, prostate cancer detection, biopsy guidance, active surveillance, and tumor staging.
• Calcium Scoring (CAC) Non-invasive CT scan of the heart that detects the amount of calcium in coronary artery walls as a measure of plaque buildup, using multidetector-row/multi-slice CT technology with low radiation dose and no contrast.
• Radiation Therapy / Oncology Treatment Comprehensive radiation therapy services for cancer treatment using advanced equipment in convenient outpatient locations with personalized, patient-focused care.
• Nuclear Medicine Diagnostic imaging utilizing radioactive tracers to visualize organ function and structure, encompassing PET imaging and other nuclear medicine studies.
• DEXA (Bone Density) Bone density scanning using dual-energy X-ray absorptiometry to measure bone mineral density and assess osteoporosis risk.
• Partner Solutions A suite of partnership-oriented service offerings including Joint Ventures, Interim & Mobile Solutions, Managed Services, Oncology Services, and Urology Solutions (mobile PET/CT, MRI, radiopharmaceuticals & staffing), enabling hospitals, health systems, and physician groups to access imaging and oncology capabilities without owning equipment.

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Siemens HealthineerscoreTechnology or IntegrationTechnology partnership for advanced imaging equipment. Akumin AXIS 1.5T MRI uses Siemens Healthineers Magnetom Viato technology, and the Akumin AXIS Drop Trailer features Siemens Healthineers Biograph Trinion PET/CT scanner.
• RadSiteminorStrategic or Co-development PartnerAkumin participates in RadSite's ADI and CBCT Standards Committees to help enhance accreditation programs in advanced diagnostic imaging and promote quality and safety standards.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/AkuminHealth
• LinkedInlinkedin.com/company/akumin
• Instagraminstagram.com/akuminhealth
• Xx.com/Tristateopenmri

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds7 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Akumin